Skip to main content
. 2020 Oct 21;35(3):437–444. doi: 10.1177/0897190020961291

Table 3.

Summary of Riociguat Rems Program Requirements.

Requirement Female of reproductive potential Pre-pubertal Post-menopausal or other medical reasons for permanent irreversible infertility
Prescriber enrolls female patients into the riociguat (Adempas) REMS program X X X
Counseling with the Adempas REMS Guide for Females Who Can Get Pregnant X
Counseling with the Riociguat (Adempas) Medication Guide, including the risk of teratogenicity X X
Prescriber must order and review pregnancy tests before starting treatment, monthly during treatment, and for 1 month after stopping treatment X
Prescriber must verify reproductive status annually by completing the “Riociguat (Adempas) REMS Change in Reproductive Potential Status and Pre-pubertal Annual Verification Form” for females who are at least 8 years of age X
Prescriber must complete the “Riociguat (Adempas) REMS Change in Reproductive Potential Status and Pre-pubertal Annual Verification Form” upon becoming aware of any changes or misclassification in reproductive status X X X

Abbreviation: REMS, risk evaluation and mitigation strategy.

Source: Adempas [package insert]. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc; 2018. 43